Ganoderic acid A
CAS: 81907-62-2
Ref. TM-T6S1141
1mg | 46,00 € | ||
5mg | 95,00 € | ||
10mg | 158,00 € | ||
25mg | 246,00 € | ||
50mg | 365,00 € | ||
100mg | 535,00 € | ||
1ml*10 (DMSO) | 108,00 € |
Información del producto
- (7Beta,15Alpha)-7,15-Dihydroxy-3,11,23-Trioxolanost-8-En-26-Oic Acid
- (7beta,15alpha,25R)-7,15-dihydroxy-3,11,23-trioxolanost-8-en-26-oic acid
- (7β,15α,25R)-7,15-Dihydroxy-3,11,23-trioxolanost-8-en-26-oic acid
- Ganoderic acid alpha
- Lanost-8-En-26-Oic Acid, 7,15-Dihydroxy-3,11,23-Trioxo-, (7Beta,15Alpha)-
- Lanost-8-en-26-oic acid, 7,15-dihydroxy-3,11,23-trioxo-, (7β,15α,25R)-
1. Ganoderic acid A exhibits antitumor activity, mediated through its inhibitory effect on nuclear transcription factor-kappaB and activator protein-1. 2. Ganoderic acid A can induce proliferation inhibition, apoptosis and suppression of invasion in human osteosarcoma HOS and MG-63 cells. 3. Ganoderic acid A promotes cisplatin-induced cell death by enhancing the sensitivity of HepG2 cells to cisplatin mainly via the signal transducer and activator of transcription 3 suppression, significantly suppresses IL-6-induced signal transducer and activator of transcription 3 phosphorylation.
Propiedades químicas
Consulta técnica sobre: TM-T6S1141 Ganoderic acid A
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.